AAAAAA
Results: 1-25/44
Authors:
TETU B
BRISSON J
PLANTE V
BERNARD P
Citation: B. Tetu et al., P53 AND C-ERBB-2 AS MARKERS OF RESISTANCE TO ADJUVANT CHEMOTHERAPY INBREAST-CANCER, Modern pathology, 11(9), 1998, pp. 823-830
Authors:
TETU B
BRISSON J
LAPOINTE H
BERNARD P
Citation: B. Tetu et al., PROGNOSTIC-SIGNIFICANCE OF STROMELYSIN-3, GELATINASE-A, AND UROKINASEEXPRESSION IN BREAST-CANCER, Human pathology, 29(9), 1998, pp. 979-985
Authors:
RAYBAUD H
FORTIN A
MORENCY R
TETU B
MONTEIL RA
Citation: H. Raybaud et al., EVALUATION OF NUCLEAR-DNA CONTENT AND KI-67 AS MARKERS OF RADIOSENSITIVITY IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC), Journal of dental research, 77, 1998, pp. 1280-1280
Authors:
ALLARD P
BERNARD P
FRADET Y
TETU B
Citation: P. Allard et al., THE EARLY CLINICAL COURSE OF PRIMARY TA AND T1 BLADDER-CANCER - A PROPOSED PROGNOSTIC INDEX, British Journal of Urology, 81(5), 1998, pp. 692-698
Authors:
RAYBAUDDIOGENE H
FORTIN A
MORENCY R
ROY J
MONTEIL RA
TETU B
Citation: H. Raybauddiogene et al., MARKERS OF RADIORESISTANCE IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK - A CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY, Journal of clinical oncology, 15(3), 1997, pp. 1030-1038
Authors:
WANG CS
LARUE H
FORTIN A
GARIEPY G
TETU B
Citation: Cs. Wang et al., MDR1 MESSENGER-RNA EXPRESSION BY RT-PCR IN PATIENTS WITH PRIMARY BREAST-CANCER SUBMITTED TO NEOADJUVANT THERAPY, Breast cancer research and treatment, 45(1), 1997, pp. 63-74
Authors:
LABRIE F
CUSAN L
GOMEZ JL
DIAMOND P
SUBURU R
LEMAY M
TETU B
FRADET Y
BELANGER A
CANDAS B
Citation: F. Labrie et al., NEOADJUVANT HORMONAL-THERAPY - THE CANADIAN EXPERIENCE, Urology, 49(3A), 1997, pp. 56-64
Authors:
GREGOIRE M
FRADET Y
MEYER F
TETU B
BOIS R
BEDARD G
CHARROIS R
NAUD A
Citation: M. Gregoire et al., DIAGNOSTIC-ACCURACY OF URINARY CYTOLOGY, AND DEOXYRIBONUCLEIC-ACID FLOW-CYTOMETRY AND CYTOLOGY ON BLADDER WASHINGS DURING FOLLOW-UP FOR BLADDER-TUMORS, The Journal of urology, 157(5), 1997, pp. 1660-1664
Authors:
TREMBLAY RR
DEPERTHES D
TETU B
DUBE JY
Citation: Rr. Tremblay et al., IMMUNOHISTOCHEMICAL STUDY SUGGESTING A COMPLEMENTARY ROLE OF KALLIKREINS HK2 AND HK3 (PROSTATE-SPECIFIC ANTIGEN) IN THE FUNCTIONAL-ANALYSISOF HUMAN PROSTATE TUMORS, The American journal of pathology, 150(2), 1997, pp. 455-459
Authors:
TETU B
Citation: B. Tetu, MORPHOLOGIC CHANGES INDUCED BY NEOADJUVANT COMBINATION HORMONE-THERAPY ON PROSTATIC TISSUE AND PROSTATE-CANCER, Endocrine-related cancer, 3(3), 1996, pp. 165-170
Authors:
RAYBAUDDIOGENE H
TETU B
MORENCY R
FORTIN A
MONTEIL RA
Citation: H. Raybauddiogene et al., P53 OVEREXPRESSION IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA - REVIEW OF THE LITERATURE, European journal of cancer. Part B, Oral oncology, 32(3), 1996, pp. 143-149
Authors:
FRADET Y
LAFLEUR L
TETU B
CORDONCARDO C
HERZ F
MAYALL BH
Citation: Y. Fradet et al., DETECTION OF C-ERBB-2 AND OTHER TUMOR-MARKERS ON BLADDER-TUMOR SPECIMENS - MARKED DIFFERENCES AFTER FORMALIN OR BOUINS FIXATION, Journal of experimental & clinical cancer research, 15(2), 1996, pp. 99-102
Authors:
VANDERKWAST TH
TETU B
Citation: Th. Vanderkwast et B. Tetu, ANDROGEN RECEPTORS IN UNTREATED AND TREATED PROSTATIC INTRAEPITHELIALNEOPLASIA, European urology, 30(2), 1996, pp. 265-268
Authors:
GERMAIN I
TETU B
BRISSON J
MONDOR M
CHERIAN MG
Citation: I. Germain et al., MARKERS OF CHEMORESISTANCE IN OVARIAN CARCINOMAS - AN IMMUNOHISTOCHEMICAL STUDY OF 86 CASES, International journal of gynecological pathology, 15(1), 1996, pp. 54-62
Authors:
VANDERKWAST TH
TETU B
FRADET Y
DUPONT A
GOMEZ J
CUSAN L
DIAMOND P
LABRIE F
Citation: Th. Vanderkwast et al., ANDROGEN RECEPTOR MODULATION IN BENIGN HUMAN PROSTATIC TISSUE AND PROSTATIC ADENOCARCINOMA DURING NEOADJUVANT ENDOCRINE COMBINATION THERAPY, The Prostate, 28(4), 1996, pp. 227-231
Authors:
VAILLANCOURT L
TETU B
FRADET Y
DUPONT A
GOMEZ J
CUSAN L
SUBURU ER
DIAMOND P
CANDAS B
LABRIE F
Citation: L. Vaillancourt et al., EFFECT OF NEOADJUVANT ENDOCRINE THERAPY (COMBINED ANDROGEN BLOCKADE) ON NORMAL PROSTATE AND PROSTATIC-CARCINOMA - A RANDOMIZED STUDY, The American journal of surgical pathology, 20(1), 1996, pp. 86-93
Authors:
ROY M
PLANTE M
RENAUD MC
TETU B
Citation: M. Roy et al., VAGINAL RADICAL HYSTERECTOMY VERSUS ABDOMINAL RADICAL HYSTERECTOMY INTHE TREATMENT OF EARLY-STAGE CERVICAL-CANCER, Gynecologic oncology, 62(3), 1996, pp. 336-339
Authors:
TETU B
ALLARD P
FRADET Y
ROBERGE N
BERNARD P
Citation: B. Tetu et al., PROGNOSTIC-SIGNIFICANCE OF NUCLEAR-DNA CONTENT AND S-PHASE FRACTION BY FLOW-CYTOMETRY IN PRIMARY PAPILLARY SUPERFICIAL BLADDER-CANCER, Human pathology, 27(9), 1996, pp. 922-926
Authors:
KRUITHOFDEKKER IG
TETU B
JANSSEN PJA
VANDERKWAST TH
Citation: Ig. Kruithofdekker et al., ELEVATED ESTROGEN-RECEPTOR EXPRESSION IN HUMAN PROSTATIC STROMAL CELLS BY ANDROGEN ABLATION THERAPY, The Journal of urology, 156(3), 1996, pp. 1194-1197
Authors:
TETU B
FRADET Y
ALLARD P
VEILLEUX C
ROBERGE N
BERNARD P
Citation: B. Tetu et al., PREVALENCE AND CLINICAL-SIGNIFICANCE OF HER-2 NEU, P53 AND RB EXPRESSION IN PRIMARY SUPERFICIAL BLADDER-CANCER/, The Journal of urology, 155(5), 1996, pp. 1784-1788
Authors:
ALLARD P
FRADET Y
TETU B
BERNARD P
Citation: P. Allard et al., TUMOR-ASSOCIATED ANTIGENS AS PROGNOSTIC FACTORS FOR RECURRENCE IN 382PATIENTS WITH PRIMARY TRANSITIONAL-CELL CARCINOMA OF THE BLADDER, Clinical cancer research, 1(10), 1995, pp. 1195-1202
Authors:
LABRIE F
CUSAN L
GOMEZ JL
DIAMOND P
SUBURU R
LEMAY M
TETU B
FRADET Y
CANDAS B
Citation: F. Labrie et al., DOWNSTAGING BY COMBINATION THERAPY WITH FLUTAMIDE AND AN LHRH AGONISTBEFORE RADICAL PROSTATECTOMY, Cancer surveys, 23, 1995, pp. 149-156
Authors:
TETU B
BRISSON J
LANDRY J
HUOT J
Citation: B. Tetu et al., PROGNOSTIC-SIGNIFICANCE OF HEAT-SHOCK PROTEIN-27 IN NODE-POSITIVE BREAST-CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY, Breast cancer research and treatment, 36(1), 1995, pp. 93-97
Authors:
HAMILTON SR
LIU B
PARSONS RE
PAPADOPOULOS N
JEN J
POWELL SM
KRUSH AJ
BERK T
COHEN Z
TETU B
BURGER PC
WOOD PA
TAQI F
BOOKER SV
PETERSEN GH
OFFERHAUS GJA
TERSMETTE AC
GIARDIELLO FM
VOGELSTEIN B
KINZLER KW
Citation: Sr. Hamilton et al., THE MOLECULAR-BASIS OF TURCOTS-SYNDROME, The New England journal of medicine, 332(13), 1995, pp. 839-847
Authors:
TETU B
PLANTE V
BRISSON J
BERNARD P
Citation: B. Tetu et al., PROGNOSTIC-SIGNIFICANCE OF P53 EXPRESSION IN NODE-POSITIVE BREAST-CARCINOMA, Laboratory investigation, 72(1), 1995, pp. 27-27